Journey Medical Corporation
USD6.93
+0.14 (+2.14%)
CEO
Claude Maraoui
IPO Date
2021-11-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$6.71
Prev. Close
$6.79
Day Low
$6.64
Day High
$7.00
52W Low
$4.31
52W High
$9.55
Market Cap
$0.19B
Volume
0.17M
| -5.4 |
| 31 Dec 2023 | FY | 66.3% | -4.9% | -18.9% | -5.0% | 0.87 | 1.35 | -27.3 |
| 31 Dec 2022 | FY | 58.2% | -40.2% | -174.5% | -28.2% | 1.35 | 1.16 | -1.1 |
| 31 Dec 2021 | FY | 49.2% | -69.7% | -104.6% | -45.2% | 0.02 | 1.64 | -2.1 |
| 31 Dec 2020 | FY | 67.2% | 11.9% | 51.3% | 10.2% | 0.96 | 1.26 | 30.0 |
| 31 Dec 2019 | FY | 69.8% | 10.4% | 131.7% | 10.7% | 1.93 | 1.21 | 43.7 |
| 31 Dec 2018 | FY | 97.2% | -523.3% | 2450.9% | -64.3% | -34.72 | 8.70 | -1.8 |
| 31 Dec 2017 | FY | 100.0% | -6678.3% | -202.6% | -54.1% | 1.87 | 5.28 | -1.3 |
| 31 Dec 2016 | FY | 100.0% | -394.4% | -36.0% | -28.5% | 0.00 | 8.12 | -5.4 |
| -37.9 |
| 30 Sept 2025 | Q3 | 67.4% | -13.1% | -8.9% | -2.7% | 0.98 | 1.42 | -19.2 |
| 30 Jun 2025 | Q2 | 60.0% | -25.3% | -19.7% | -4.7% | 1.31 | 1.27 | -11.0 |
| 31 Mar 2025 | Q1 | 55.4% | -31.0% | -18.9% | -4.8% | 1.17 | 1.34 | -8.2 |
| 31 Dec 2024 | Q4 | 83.6% | 11.2% | 7.6% | 1.9% | 1.28 | 1.37 | 14.2 |
| 30 Sept 2024 | Q3 | 63.9% | -16.3% | -21.9% | -3.7% | 1.81 | 1.38 | -12.1 |
| 30 Jun 2024 | Q2 | 56.0% | -22.6% | -29.8% | -5.2% | 2.02 | 1.36 | -8.0 |
| 31 Mar 2024 | Q1 | 47.7% | -80.1% | -80.6% | -15.7% | 1.37 | 1.21 | -1.6 |
| 31 Dec 2023 | Q4 | 60.6% | -14.0% | -10.5% | -2.8% | 0.87 | 1.35 | -13.0 |